Sutro Biopharma, Inc.
A clinical-stage pharmaceutical company focused on discovering, developing, and manufacturing next-generation protein therapeutics. The company develops protein therapies, including antibody-drug conjugates, using its cell-free protein synthesis technology, XpressCF, for the treatment of cancer and autoimmune diseases. Targeted cancers include multiple myeloma, non-Hodgkin's lymphoma, ovarian cancer, and endometrial cancer. Delaware-based.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 300 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 340.26M |
Revenue | 154.06M |
Operating Income | -103.63M |
Operating Margin | -67.27% |
Net Income | -114.96M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4809 / 5373 |
Sector : Healthcare | 892 / 1144 |
Industry : Biotechnology | 459 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3261 / 5565 |
Sector : Healthcare | 500 / 1182 |
Industry : Biotechnology | 243 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4822 / 5436 |
Sector : Healthcare | 920 / 1164 |
Industry : Biotechnology | 484 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3277 / 5330 |
Sector : Healthcare | 385 / 1174 |
Industry : Biotechnology | 92 / 667 |